Checkpoint Surgical
Cleveland, US · Founded 2009 · Delaware corporation · 74 employees on LinkedIn · 6 known investors
Checkpoint Surgical develops intraoperative nerve stimulation devices, biomaterial implants, and surgical instruments for peripheral nerve and tendon surgery. The company produces ACMShield, a dehydrated placental membrane allograft used as a protective barrier in surgical applications.
Also known as CheckPoint Surgical · Checkpoint Surgical, Inc.
Founders & leadership
Board
Investors · 6
Also in the syndicate · 1
Reported raises · per SEC filings
Form D private placements$42.7M disclosed across 6 of 7 rounds · 2011–2024
▶$4MraisedJun 2024 · 42 investors · OtherRule 506(b)
- Michael ChuisanoDirector
- Tracy MarshbanksDirector
- Carter McNabbDirector
- Derek LewisExecutive Officer, Director
- Geoffrey ThropeDirector
- Wayne WallaceDirector
- Raymond RackleyDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13MraisedJun 2021 · 6 investors · Other Health CareRule 506(b)
- Leonard M. CosentinoExecutive Officer, Director
- Carter McNabbDirector
- Geoffrey B. ThropeExecutive Officer, Director
- Raymond RackleyDirector
- Wayne WallaceDirector
- Tracy MarshbanksDirector
- Donald HubbardExecutive Officer
- Michael ChuisanoDirector
- Laura KeckExecutive Officer
- Kevin M. ScanlanExecutive Officer
- Derek LewisExecutive Officer
- Richard DiBlasiExecutive Officer
- Offering amount
- $16M
- Amount sold
- $13M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedMay 2020 · 10 investors · Other Health CareRule 506(b)
- Kevin M. ScanlanExecutive Officer
- Laura KeckExecutive Officer
- Leonard M. CosentinoExecutive Officer, Director
- Geoffrey B. ThropeExecutive Officer, Director
- Richard DiBlasiExecutive Officer
- Tracy MarshbanksDirector
- Donald HubbardExecutive Officer
- Michael ChuisanoDirector
- Raymond RackleyDirector
- Wayne WallaceDirector
- Derek LewisExecutive Officer
- Offering amount
- $5M
- Amount sold
- $1.9M
- Minimum investment
- $25K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$8.8MraisedSep 2018 · 31 investors · Other Health CareRule 506(b)
- Raymond RackleyDirector
- Leonard M. CosentinoExecutive Officer, Director
- Kevin M. ScanlanExecutive Officer
- Geoffrey B. ThropeExecutive Officer, Director
- Tracy MarshbanksDirector
- Wayne WallaceDirector
- Laura KeckExecutive Officer
- Richard DiBlasiExecutive Officer
- Donald HubbardExecutive Officer
- Offering amount
- $9M
- Amount sold
- $8.8M
- Minimum investment
- $10K
- Sales commissions
- $100K
- Placement agents
- Beech Hill Securities, Inc.
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$7.5MraisedNov 2015 · 29 investors · Other Health CareRule 506(b)
- Tracy MarshbanksDirector
- Geoffrey B. ThropeExecutive Officer, Director
- Leonard M. CosentinoExecutive Officer, Director
- Marilyn A. EiseleExecutive Officer
- Kevin M. ScanlanExecutive Officer
- Donald HubbardExecutive Officer
- Offering amount
- $9.5M
- Amount sold
- $7.5M
- Minimum investment
- $25K
- Sales commissions
- $350K
- Placement agents
- Beech Hill Securities, Inc.
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$7.5MraisedJul 2014 · 40 investors · Other Health CareRule 506(b)
- Mark StultzExecutive Officer
- Leonard CosentinoExecutive Officer, Director
- Donald HubbardExecutive Officer, Director
- Geoffrey ThropeExecutive Officer, Director
- Scott ZeilingerDirector
- Marilyn EiseleExecutive Officer
- Offering amount
- $10M
- Amount sold
- $7.5M
- Minimum investment
- $9.2K
- First sale
- May 2011
- Incorporated
- Limited Liability Company, Ohio, 2009
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026Checkpoint Surgical, Inc. is a privately held US medical device company focused on peripheral nerve protection, repair and regeneration. Its portfolio spans intraoperative nerve stimulation devices, biomaterial implants and instruments used in nerve and tendon surgery. Named products include the CHECKPOINT GUARDIAN nerve stimulator and its Intraoperative Lead Accessory, the CHECKPOINT GEMINI bipolar nerve stimulator, the CHECKPOINT ACMShield soft tissue barrier, the CHECKPOINT EDGE nerve cutting kit, the CHECKPOINT AxioCor flexible nerve conduit and the NeuroShield nerve wrap. The company's earlier flagship product was the CHECKPOINT Stimulator/Locator, a single-use, hand-held stimulator with surgeon-controllable stimulation parameters, designed by a team of orthopedic surgeons and biomedical engineers.
The company also develops the investigational Regen10 nerve regeneration system, which is the subject of the multi-center FASTR-TEN clinical trial and received Health Canada approval announced in July 2026. Alongside its commercial products, Checkpoint runs surgeon education programs including a virtual lecture series, an education calendar, cadaveric courses and an annual Nerve Summit held at its Cleveland headquarters.
The company states its mission as advancing the science and practice of nerve protection and repair, working with surgeon partners on research, education and product development.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 2
by search overlap
Companies competing with Checkpoint Surgical for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 16
launches, deals, and filingsCheckpoint hosted its 4th Annual Nerve Summit on August 14-15, 2026 at its Cleveland headquarters for peripheral nerve surgeons.
Checkpoint Surgical announced the addition of the CHECKPOINT AxioCor Flexible Nerve Conduit to its peripheral nerve repair and regeneration portfolio.
The company reported that surgeon adoption drove a distribution milestone for its ACMShield soft tissue barrier.
Checkpoint Surgical hosted the Surgery of the Spastic Upper Limb Cadaveric Course in Las Vegas on October 24-25, 2025 for plastic and orthopedic surgeons.
Addition to the company's intraoperative nerve stimulator line, designed to deliver more precise stimulation.
First offering in the company's planned portfolio of nerve-specific surgical instruments.
First patient enrolled at The Ohio State University in a double-blind, randomized multi-center study of the company's nerve regeneration technology; other sites include the Medical College of Wisconsin, Northwestern University and Walter Reed National Military Medical Center. The study is also funded by a Department of Defense Clinical Trial Award to Dr. Amy Moore at The Ohio State University.
Full commercial release of the Checkpoint Guardian Nerve Stimulator plus FDA clearance and market launch of the Checkpoint Guardian Intraoperative Lead Accessory, announced at the 2021 ASSH meeting.
Capital raise to support sales force expansion, multiple new product launches including the recently acquired NeuroShield nerve wrap, and continued R&D.
$16M source ↗
The 2021 financing release refers to the recently acquired NeuroShield nerve wrap among products planned for launch.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
Legal entities · 1
corporate structure▸Research sources · 8
primary sources listed
- Checkpoint Surgicalcheckpointsurgical.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Checkpoint Surgical do?
- Cleveland-area medical device company making intraoperative nerve stimulators, biomaterial implants and instruments for peripheral nerve surgery.
- Who are Checkpoint Surgical's investors?
- Checkpoint Surgical's investors include First Analysis, Jumpstart Ventures, Mutual Capital Partners, NDI, RC Capital.
- How much funding has Checkpoint Surgical raised?
- Checkpoint Surgical has disclosed $42.7M raised across 6 of its 7 known rounds.
- Where is Checkpoint Surgical headquartered?
- Checkpoint Surgical is headquartered in Cleveland, US.